Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tailored Analytical Testing and Stability Services services provided by Lgm Pharma

Lgm Pharma
Tailored Analytical Testing and Stability Services

PDF Upload Mar, 2025

LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities

12 Mar 2025

// BUSINESSWIRE

N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy

18 Nov 2024

// PRESS RELEASE

New Harbor Capital Portfolio Company LGM Pharma Promotes CFO& CCO

22 Oct 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

LGM Pharma RMU

Contact Supplier

Interphex

Booth #3514

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

Xls

CATEGORY PAGE

Lgm Pharma

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Corporate Presentation, Tailored Analytical Testing and Stability Services, Five Reasons to Outsource API Procurement

Product List 2025
Corporate Presentation
Tailored Analytical Testing and Stability Services
Five Reasons to Outsource API Procurement

VIDEO(s)

Challenges with Sourcing Pharmaceutical APIs, DCAT Member Company Announcement Forum, Regulatory Considerations for API Sourcing, Risk Mitigation for Supply Chain Challenges, Sourcing Concerns for Smaller Pharma Companies, Supply Chain Logistics Trends, Value of Finding a Capacity Match Early On

Challenges with Sourcing Pharmaceutical APIs
DCAT Member Company Announcement Forum
Regulatory Considerations for API Sourcing
Risk Mitigation for Supply Chain Challenges
Sourcing Concerns for Smaller Pharma Companies
Supply Chain Logistics Trends
Value of Finding a Capacity Match Early On

DIGITAL CONTENT

2 Interview #SpeakPharma, 11 Corporate Content #SupplierSpotlight, 2 Data Compilation #PharmaFlow, 19 News #PharmaBuzz

2 Interview #SpeakPharma
11 Corporate Content #SupplierSpotlight
2 Data Compilation #PharmaFlow
19 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

583 All APIs, 583 Listed APIs

583 All APIs
583 Listed APIs

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers, 17 FDA Orange Book

17 FDF Dossiers
17 FDA Orange Book

KEY PRODUCTS

Beta Nicotinamide Adenine Dinucleotide, Bupropion Hydrobromide, Bupropion Hydrochloride, Doxorubicin Hydrochloride, Ketamine Hydrochloride, Lidocaine, Lidocaine Hydrochloride, Naltrexone, Naltrexone Hydrochloride, Naltrexone Methobromide, Pilocarpine Hydrochloride, Polidocanol, Salcaprozate Sodium, Sirolimus, Sodium Tetradecyl Sulfate, Sucralfate, Tesamorelin Acetate, Topiramate, Trastuzumab, Trastuzumab Emtansine

Beta Nicotinamide Adenine Dinucleotide
Bupropion Hydrobromide
Bupropion Hydrochloride
Doxorubicin Hydrochloride
Ketamine Hydrochloride
Lidocaine
Lidocaine Hydrochloride
Naltrexone
Naltrexone Hydrochloride
Naltrexone Methobromide
Pilocarpine Hydrochloride
Polidocanol
Salcaprozate Sodium
Sirolimus
Sodium Tetradecyl Sulfate
Sucralfate
Tesamorelin Acetate
Topiramate
Trastuzumab
Trastuzumab Emtansine

SERVICES

Drug Product Manufacturing, Analytical, API & Drug Product Development

Drug Product Manufacturing
Analytical
- 2 Analytical Testing Services
API & Drug Product Development
- 7 Formulation Development

KEY SERVICES

Capsule Contract Manufacturing, Contract Manufacturing for Tablets, Coated Tablet Manufacturing, Controlled Substance Tablets, ODT Contract Manufacturing, Immediate & Controlled Release Tablets, Extended Release Tablet Manufacturing, Sustained Release Tablet Manufacturing

Capsule Contract Manufacturing
Contract Manufacturing for Tablets
Coated Tablet Manufacturing
Controlled Substance Tablets
ODT Contract Manufacturing
Immediate & Controlled Release Tablets
Extended Release Tablet Manufacturing
Sustained Release Tablet Manufacturing

INSPECTIONS & REGISTRATIONS

27 FDA, 1 GDUFA

27 FDA
1 GDUFA

PC102949

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!